TrivarX Limited (ASX:TRI)

Market Cap	7.41M
Revenue (ttm)	2.00M
Net Income (ttm)	-440.20K
Shares Out	570.21M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,153
Average Volume	709,284
Open	0.0120
Previous Close	0.0120
Day's Range	0.0120 - 0.0130
52-Week Range	0.0100 - 0.0450
Beta	0.88
RSI	46.18
Earnings Date	May 29, 2025

About TrivarX

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1987
• Employees: 6
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TRI

Financial Performance

In 2024, TrivarX's revenue was 888,829, a decrease of -7.46% compared to the previous year's 960,451. Losses were -1.43 million, -53.28% less than in 2023.